Outcomes4Me Inc., a Cambridge, Mass.-based developer of an Artificial Intelligence (AI)-powered platform to empower cancer patients to navigate their care, raised $12m in Series A funding round.
The round was led by Northpond Ventures, with participation from all existing investors, including Sierra Ventures, Asset Management Ventures, Merstal Ltd, IRA Capital, and others. Andrea Jackson, a Northpond Ventures Director, will join Outcomes4Me’s board.
The company intends to use the funds to extend its platform beyond breast cancer to other cancers, grow the platform’s regulatory-grade dataset, and expand to more patients in Europe.
Co-founded in 2017 by Maya R. Said, Sc. D., CEO, and Dr. Osama Rahma, Chief Medical Advisor, who were later joined by Chief Operating Officer Sami Shalabi, a former Google executive who sold his company to Google and co-founded and led Google Play Newsstand and the all-new Google News, growing both to over a billion users, Outcomes4Me has dev
MedCity News
Read about new developments from Seven Bridges, Blue Therapeutics, Outcomes4Me and more.
Shares0
Seven Bridges this week announced the close of the first $15 million of a planned $30 million Series C round from a new life sciences investor. This investment will support the company in its mission to accelerate scientific discovery and speed the path from raw experimental data to new treatments and diagnostics.
“Multi-omics tools are fast-becoming ubiquitous drivers of scientific innovation. As the industry’s leading enterprise bioinformatics ecosystem provider, Seven Bridges provides its clients the ability to facilitate discovery by helping researchers generate meaningful insights from vast quantities of data,” said William Moss, chief executive officer of Seven Bridges. “This new investment is a recognition of the leading role Seven Bridges plays in the future of biomedical innovation and will help us continue to innovate and scale our organization to serv
Outcomes4Me Raises $12M for AI-Powered Cancer Patient Empowerment Platform
What You Should Know:
– Outcomes4Me Inc., a Cambridge, MA-based developer of an Artificial Intelligence (AI)-powered platform to empower cancer patients to navigate their care, today announced it has raised $12 million in an oversubscribed Series A round led by Northpond Ventures, with participation from all existing investors, including Sierra Ventures, Asset Management Ventures, Merstal Ltd, IRA Capital, and others. Andrea Jackson, a Northpond Ventures Director, will join Outcomes4Me’s board.
– After experiencing first-hand the challenges of being a patient, Dr. Said, a former Senior Vice President and Global Head of Oncology Policy and Market Access at Novartis, co-founded Outcomes4Me in 2017, with the company’s Chief Medical Advisor, Dr. Osama Rahma, a National Institutes of Health (NIH)-trained practicing oncologist at Dana-Farber Cancer Institute and the Clinical Director of its Center f
(0)
Funding to Accelerate Hiring as Outcomes4Me Diversifies Cancer Support and Expands to Empower Patients in Europe
CAMBRIDGE, Mass., April 28, 2021 /PRNewswire/ Outcomes4Me Inc., developer of an Artificial Intelligence (AI)-powered platform to empower cancer patients to navigate their care, today announced it has raised $12 million in an oversubscribed Series A round. Funds will be used to extend Outcomes4Me s platform beyond breast cancer to other cancers, grow the platform s regulatory-grade dataset, and expand to more patients in Europe.
The round was led by Northpond Ventures, with participation from all existing investors, including Sierra Ventures, Asset Management Ventures, Merstal Ltd, IRA Capital, and others. Andrea Jackson, a Northpond Ventures Director, will join Outcomes4Me s board.
Carta Healthcare Raises $17.3M for AI-Assisted Data Abstraction
What You Should Know:
– Carta Healthcare, a provider of AI-powered clinical data abstraction technology and services, is pleased to announce a recent $17.3M Series A investment led by Storm Ventures. AI Digital Innovation Fund (affiliated with Mass General Brigham), CU Health Innovation Fund (affiliated with University of Colorado Anschutz Medical Campus), Asset Management Ventures, Maverick Ventures, Healthy Ventures, Waterline Ventures, Seven Peaks Ventures, Katalyst Ventures, and Atypical Ventures also participated in the round.
– Founded in 2017, Carta Healthcare uses industry-leading artificial intelligence (AI) technology to collect, analyze, and act upon clinical data. Through natural language processing and machine learning, Carta’s technology dramatically reduces the labor associated with manual data abstraction processes typically required to curate trustworthy, actionable datasets.